Cancer Treatment Reviews
Volume 30, Issue 5 , Pages 415-423 , August 2004

Modulation of the blood–brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?

  • E.Marleen Kemper

      Affiliations

    • Department of Clinical Chemistry, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Huis, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    • ,
  • Willem Boogerd

      Affiliations

    • Department of Neurology, Slotervaart Hospital, Louwesweg 6, 1066 EC Amsterdam, The Netherlands
    • Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Huis, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    • ,
  • Ingrid Thuis

      Affiliations

    • Department of Clinical Chemistry, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Huis, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    • ,
  • Jos H Beijnen

      Affiliations

    • Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Huis, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Louwesweg 6, 1066 EC Amsterdam, The Netherlands
    • Division of Drug Toxicology, Faculty of Pharmaceutical Sciences, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands
    • ,
  • Olaf van Tellingen

      Affiliations

    • Department of Clinical Chemistry, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Huis, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31-20-512-2792; fax: +31-20-512–2799

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(04)00075-1

doi: 10.1016/j.ctrv.2004.04.001

Cancer Treatment Reviews
Volume 30, Issue 5 , Pages 415-423 , August 2004

Article Tools

* Image Usage & Resolution